Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.

Sergio Muñoz-Martínez,Victor Sapena,Ángeles García-Criado,Anna Darnell,Alejandro Forner,Ernest Belmonte,Marco Sanduzzi-Zamparelli,Jordi Rimola,Alexandre Soler,Neus Llarch,Gemma Iserte,Ezequiel Mauro,Carmen Ayuso,Jose Rios,Jordi Bruix,Ramon Vilana,María Reig

Cancers（2023）

引用 0|浏览31

暂无评分

摘要

These results expose the impact of non-liver comorbidities when considering treatment for recurrence after ablation in the real-world setting and in research trials. Ultimately, we identified an orphan population for which effective interventions are needed.

查看译文

关键词

hepatocellular carcinoma, ablation, comorbidities, elderly, clinical decision-making, survival, pattern of progression

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要